U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209363

Marketing Status: Prescription
Active Ingredient: SECNIDAZOLE
Proprietary Name: SOLOSEC
Dosage Form; Route of Administration: GRANULE; ORAL
Strength: 2GM/PACKET
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209363
Product Number: 001
Approval Date: Sep 15, 2017
Applicant Holder Full Name: LUPIN INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top